Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

1995 Vol. 13, No. 1

Cover
Display Method:
1995, (1): 3-6.
Abstract:
1995, (1): 6-7.
Abstract:
1995, (1): 7-7.
Abstract(2515) PDF (976KB)(767)
Abstract:
Comparision of bactericidal activity in cerebrospinal fluid of three cephalosporins in the patients undergoing surgery of skull and brain
Wang Rui, Zhao Zhi-jian, Chen Qian, Li Yong, Zhang Yuan-zheng, Tan Ci-e, Pei Bao-xiang, Chen Meng-li
1995, (1): 8-12.
Abstract:
The bactericidal activity of serum and cerebrospinal fluid(SBA and CBA) of ceftriaxone(CTRX、cefotaxime(CTX))、cefuroxime(CFR)in the patients undergoing surgery of skull and brain were studied by means of microdiluted method.The results showed antibacterial activity of CTRX against Enterobactericeae in vitro or in serum and cerebrospinal fluid(CSF) was the highest,it is suggested that the schadule of lg of CTRX per 12hr may be used in prevention and treatment of serious infections after surgery of skull and brain.The bactericidal activity of CTX against Gram's positive strains and Enterobactericeae in serum and CSF were higher,CTX may be used in infections of nervous system caused by mixed bacteria.The SBA and CBA of CFR were less,but its antibacterial spectrum was wide and the cost was lower,so CFR may be selected in the moderate infections.The CBA was a synthesized guide reflexing the antibactial activity and penetration into barrier,so it is recommanded reference to selected antibiotis infections after surgery of skull and brain.
A new antineoplastic drug-Paclitaxel
Zhu Quan-gang, Wei Shui-yi
1995, (1): 12-14.
Abstract:
The Clinical Pharmacology,adverse reactions,Clinical uses,and precautions of Paclitaxel were reviewed.
1995, (1): 15-16.
Abstract:
1995, (1): 17-18.
Abstract:
1995, (1): 19-20.
Abstract:
1995, (1): 20-22.
Abstract:
1995, (1): 22-22.
Abstract(1865) PDF (949KB)(641)
Abstract:
1995, (1): 23-23.
Abstract:
1995, (1): 24-24.
Abstract(1755) PDF (307KB)(400)
Abstract:
1995, (1): 24-26.
Abstract:
1995, (1): 27-28.
Abstract:
1995, (1): 28-29.
Abstract:
Determination of Two Components in Naristillae Chloramphenicoliet Ephedrini Hydrochloridi by convolution curve method
Wu Xiao-Fang, Huang Yan-Min, Song hong-jie, Li shu-Tong, Guo jian-ping
1995, (1): 30-32.
Abstract:
This paper reports the determination of Ephedrini Hydrochloridi and Chloramphenicoli and Chloramphenicoli in Naristillae Chloramphenicoli et Ephedrini hydrochloridi by the convolution cure method and without prior separation.The average recovery and RSD of Ephedrini Hydrochloridi and Chloramphenicoli were as follows 99.80%,0.57%; 99.18%,0.74%.
UV-Spectrophotometry for quantitative determination of Norfloxacin Capsule
Yan Jia-wei, Chen Pei-lin, Fang De-ming
1995, (1): 32-34.
Abstract:
The paper reported the direct determination of norfloxacin capsules by UVspectrophotometry. The result shows:This method is simple,accurate and reproducible.The calibration curve is linear in the range from 4.816μg/ml to 14.448μg/ml(r=0.9999)RSD=0.64%
UV-Spectrophotometry for quantitative determination of phenyl salicylate in the cream for highland
Liu Ming-Zong
1995, (1): 34-36.
Abstract:
Recent progress in studies on the pharmacological actions and clinical applications of leech
Wu Hao, Yuan Bo-jun
1995, (1): 37-39.
Abstract:
The study on dentification of pharmacognsy and anti-neoplasm of Juglans mandshurica
Wang Shao-Lin, Wang Shao-dong, Liu Jin-fang
1995, (1): 40-42.
Abstract:
1995, (1): 42-43.
Abstract:
1995, (1): 44-46.
Abstract:
1995, (1): 46-47.
Abstract:
1995, (1): 48-48.
Abstract(2003) PDF (544KB)(391)
Abstract:
1995, (1): 48-49.
Abstract:
1995, (1): 49-50.
Abstract:
1995, (1): 50-50.
Abstract(1919) PDF (497KB)(403)
Abstract:
1995, (1): 51-56.
Abstract:
1995, (1): 56-57.
Abstract:
1995, (1): 58-59.
Abstract(1654) PDF (551KB)(365)
Abstract:
1995, (1): 59-59.
Abstract(1911) PDF (375KB)(405)
Abstract:
1995, (1): 59-61.
Abstract:
1995, (1): 61-62.
Abstract(2149) PDF (940KB)(366)
Abstract: